Market Research Logo

Russia Pharmaceuticals & Healthcare Q3 2018

Russia Pharmaceuticals & Healthcare Q3 2018

BMI View:

While Russia remains a key emerging market for multinational drugmakers, the country's economic outlook willcontinue to drive performance given the low state footprint in drug expenditure. Pharmaceutical policy continuity will lead toincreased investment in localised drug production in the market, although this will remain heavily weighted towards the genericmedicines sector given the continued regulatory issues and market access barriers for innovative drugmakers.


BMI Industry View
SWOT
Industry Forecast
Pharmaceutical Market Forecast
Healthcare Market Forecast
Prescription Drugs Market Forecast
Patented Drugs Market Forecast
Generic Drugs Market Forecast
OTC Medicine Market Forecast
Pharmaceutical Trade Forecast
Industry Risk/Reward Index
Central And Eastern Europe Pharmaceuticals Risk/Reward Index
Russia Risk/Reward Index
Regulatory Development
Regulatory Review
Market Overview
Competitive Landscape
Company Profile
Johnson & Johnson
Novartis
Pharmstandard
Veropharm
Demographic Forecast
Demographic Outlook
Pharmaceuticals & Healthcare Glossary
Pharmaceuticals & Healthcare Methodology

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report